Results 1 -
10
of
16
for
Ponatinib
- Ponatinib is used to treat certain types of chronic myeloid leukemia (CML; a type of cancer of ... cannot take these medications because of side effects. Ponatinib is also used to treat certain types of ...
- Chronic myeloid leukemia is a slow-growing cancer of the blood-forming tissue (bone marrow). Normal bone marrow produces red blood cells (erythrocytes) that carry ...
- The ABL1 gene provides instructions for making a protein involved in many processes in cells throughout the body. The ABL1 protein functions as a kinase, ...
- The BCR gene provides instructions for making a protein whose function is not completely understood. Studies show that the BCR protein may act as a GTPase ...
- This page lists cancer drugs approved by the FDA for use in leukemia. The drug names link to NCI's Cancer Drug Information summaries. The list includes ...
- Treating Chronic Myeloid Leukemia by Phase (American Cancer Society)Chronic Myeloid Leukemia/Treatments and Therapies ... Chronic Myeloid Leukemia ... American Cancer Society ... Treatment options for chronic myeloid leukemia are based ...
- A to Z List of Cancer Drugs (National Cancer Institute)Cancer Chemotherapy/Start Here ... Cancer Chemotherapy ... Cancer/Treatments and Therapies ... Cancer ... List of cancer drug information summaries providing details about ...
- Index to Drug-Specific Information (Food and Drug Administration)Drug Reactions/Related Issues ... Drug Reactions ... Pregnancy and Medicines/Related Issues ... Pregnancy and Medicines ... Medicines/Start Here ... Medicines ... Looking for drug ...
- LiverTox: Clinical and Research Information on Drug-Induced Liver Injury
(National Library of Medicine) (National Institute of Diabetes and Digestive and Kidney Diseases)
LiverTox® provides up-to-date, unbiased and easily accessed information on the diagnosis, cause, frequency, clinical patterns and management of liver ... - Chronic myelogenous leukemia treatment may include targeted therapy, immunotherapy, chemotherapy, stem cell transplant, donor lymphocyte infusion, and/ ...